Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 24 studies | 29% ± 12% | |
macrophage | 14 studies | 26% ± 5% | |
conventional dendritic cell | 12 studies | 28% ± 9% | |
memory B cell | 12 studies | 29% ± 12% | |
mast cell | 11 studies | 32% ± 12% | |
naive B cell | 10 studies | 31% ± 13% | |
dendritic cell | 8 studies | 38% ± 14% | |
monocyte | 8 studies | 26% ± 9% | |
plasmacytoid dendritic cell | 8 studies | 32% ± 17% | |
classical monocyte | 7 studies | 23% ± 8% | |
myeloid cell | 7 studies | 30% ± 9% | |
natural killer cell | 6 studies | 25% ± 6% | |
precursor B cell | 5 studies | 31% ± 6% | |
mononuclear phagocyte | 4 studies | 26% ± 11% | |
immature B cell | 4 studies | 32% ± 20% | |
leukocyte | 3 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 785.95 | 180 / 180 | 100% | 15.40 | 429 / 430 |
esophagus | 99% | 489.30 | 1436 / 1445 | 99% | 7.75 | 182 / 183 |
uterus | 100% | 554.29 | 170 / 170 | 98% | 8.16 | 449 / 459 |
thymus | 100% | 990.65 | 652 / 653 | 97% | 8.30 | 584 / 605 |
bladder | 100% | 530.81 | 21 / 21 | 96% | 6.37 | 485 / 504 |
intestine | 100% | 565.74 | 964 / 966 | 96% | 5.93 | 508 / 527 |
lung | 100% | 1511.49 | 578 / 578 | 95% | 6.50 | 1097 / 1155 |
stomach | 97% | 371.32 | 347 / 359 | 97% | 6.05 | 276 / 286 |
breast | 100% | 676.79 | 459 / 459 | 93% | 5.34 | 1038 / 1118 |
pancreas | 92% | 267.29 | 302 / 328 | 97% | 7.14 | 173 / 178 |
kidney | 100% | 629.37 | 89 / 89 | 86% | 7.76 | 772 / 901 |
skin | 98% | 416.92 | 1767 / 1809 | 86% | 4.13 | 406 / 472 |
adrenal gland | 99% | 468.65 | 255 / 258 | 84% | 4.70 | 194 / 230 |
prostate | 100% | 639.43 | 245 / 245 | 76% | 3.07 | 383 / 502 |
brain | 84% | 342.06 | 2216 / 2642 | 84% | 5.21 | 593 / 705 |
liver | 69% | 185.62 | 156 / 226 | 32% | 1.30 | 128 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 66.69 | 29 / 29 |
peripheral blood | 100% | 3729.29 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 1406.46 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.52 | 1 / 1 |
adipose | 100% | 807.11 | 1199 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 8.61 | 44 / 45 |
blood vessel | 86% | 328.49 | 1142 / 1335 | 0% | 0 | 0 / 0 |
heart | 62% | 210.98 | 530 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 34% | 0.92 | 27 / 80 |
muscle | 7% | 13.92 | 56 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010468 | Biological process | regulation of gene expression |
GO_0006954 | Biological process | inflammatory response |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_2000321 | Biological process | positive regulation of T-helper 17 cell differentiation |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | NFKBID |
Protein name | NF-kappa-B inhibitor delta (NFKB inhibitor delta) (I-kappa-B-delta) (IkB-delta) (IkappaBdelta) (IkappaBNS) (T-cell activation NFKB-like protein) (TA-NFKBH) NFKB inhibitor delta |
Synonyms | IKBNS |
Description | FUNCTION: Regulates the expression of IL-2, IL-6, and other cytokines through regulation on NF-kappa-B activity. Functions in the regulation of inflammatory responses. Involved in the induction of T helper 17 cells (Th17) differentiation upon recognition of antigen by T cell antigen receptor (TCR). May also regulate TCR-induced negative selection of thymocytes. . |
Accessions | ENST00000585925.7 ENST00000606253.5 [Q8NI38-2] ENST00000641389.3 A0A286YF31 Q8NI38 K7EKM2 ENST00000590828.5 ENST00000396901.5 [Q8NI38-1] K7ENW9 |